Evidence map›Paper›PMID 36299951›Full record

ArticleCureus2022

Prevalence of Cardiovascular Risk Factors Among Patients With Diabetes Mellitus Type 2 at King Fahad University Hospital, Saudi Arabia.

Noor-Ahmed Jatoi, Yasir A Elamin, Abir H Said, Basher Al-Namer, Fatimah A Al-Muallim, Fatimah F Al-Nemer, Fatimah M Al-Halal

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06674161 (The Impact of Type 2 Diabetes Mellitus on Cardiovascular Events in Saudi Arabia Now and Future), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06674161 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

The Impact of Type 2 Diabetes Mellitus on Cardiovascular Events in Saudi Arabia Now and Future

TypeobservationalSponsorKing Faisal Specialist Hospital & Research CenterRan2024 to 2030Enrolled80ConditionsMortality of Patients with CVD, Mortality of Patients with CVD and T2DM, Mortality of Patients with T2DM, Mortality of Patients with Neither
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Noor-Ahmed JatoiInternal Medicine (Vascular Medicine), King Fahad University Hospital, Imam Abdulrahman Bin Faisal University, Al-Khobar, SAU.
Yasir A ElaminInternal Medicine (Diabetes and Endocrinology), King Fahad University Hospital, Imam Abdulrahman Bin Faisal University, Al-Khobar, SAU.
Abir H SaidInternal Medicine (Pulmonolgy), King Fahad University Hospital, Imam AbdulRahman Bin Faisal University, Al-Khobar, SAU.
Basher Al-NamerInternal Medicine, Imam AbdulRahman Bin Faisal University, Al-Khobar, SAU.
Fatimah A Al-MuallimInternal Medicine, College of Medicine, Imam AbdulRahman Bin Faisal University, Al-Khobar, SAU.
Fatimah F Al-NemerInternal Medicine, Imam AbdulRahman Bin Faisal University, Al-Khobar, SAU.
Fatimah M Al-HalalInternal Medicine, Imam AbdulRahman Bin Faisal University, Al-Khobar, SAU.
Imam Abdulrahman Bin Faisal University · SAImam Abdulrahman Al Faisal Hospital · SAKing Fahd Hospital of the University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Diabetes mellitus is considered a major risk factor for cardiovascular diseases. Patients with diabetes mellitus type 2 (DM-II) are at twice as high risk for the development of cardiovascular diseases than the general population. Thus, we aimed to assess the most prevalent cardiovascular risk (CVR) factors among DM-II patients in the Eastern province of Saudi Arabia. Method This is a cross-sectional, retrospective, and observational study conducted on DM-II patients at King Fahad University Hospital (KFUH) Al Khobar, Saudi Arabia, from January 2016 to December 2021. The total number of participants was 373 who were patients with DM-II. The patients' demographic information (age, sex, marital status, height, weight, body mass index (BMI), waist, hip circumference, and waist-hip ratio were calculated or obtained from hospital electronic records as were the CVR factors, age, gender, smoking habits, physical activity, BMI, haemodynamic measurements, glycosylated haemoglobin (HbA1C) levels and lipid profile. The collected data were analyzed by using SPSS Statistics v.28 (IBM Corp., Armonk, NY). The descriptive statistics were reported using mean±SD for numerical data and relative frequencies (%) for categorical data. P < 0.05 were counted significant. Quantitative data were analyzed using the ANOVA test to compare the means of the three groups. Qualitative data were analyzed and compared using the chi-square test. Fisher's exact test was also used to study the statistical significance of variables. Spearman rank correlation was used to study the relationship between HbA1C and other CV risk factors.  Results The mean age was 58 (± 13) years; females were 57% of the sample. Around 92% were smokers, 84% had a sedentary lifestyle, 72% had dyslipidemia, 58% were obese, 30% were overweight, 58% reported poorly control of their diabetes, 50% had hypertension and 32% had pre-hypertension. Furthermore, 89% of participants had two or more CVR factors other than DM-II. We found a significant association between high body mass index, dyslipidemia, high systolic blood pressure and pulse pressure (p<0.05) with HbA1C. Conclusion The majority of participants had two or more cardiovascular risk factors in addition to DM-II. Poor control of DM-II and cardiovascular risk factors cannot be ignored and primary to tertiary prevention must be the top priority when managing the diabetic population in order to prevent devastating outcomes and progression of reversible morbidity.

Indexed as

cardiovascular risk factorsdiabetes mellitusdyslipedemiahaemodynamic measurementshba1c

Identifiers

PMID36299951
PMCPMC9588283
OpenAlexW4296838025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.